Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586833 · ClinicalTrials.gov registry record
Heart Failure and a Preserved Ejection Fraction
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 51
- Enrollment target
NCT00586833: Completed study, sponsored by Mayo Clinic.
NCT00586833 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00586833 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This will be a cross sectional study comparing patients with HFpEF and age-matched, non-HF controls recruited from the community. This design will allow for determination of biologically relevant differences in baseline ventricular and vascular function, and importantly, differences in the ability to augment ventricular and vascular function dynamically during exercise stress, when symptoms of HF typically are first noted. The endpoint of exercise-reserve function is novel and has been little examined in the existing HFpEF literature.
Interventions
- PROCEDURE O2 consumption max bike test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00586833
The ClinicalTrials.gov registry entry for NCT00586833 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which O2 consumption max bike test is the first listed.
NCT00586833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00586833 about?
NCT00586833 is a clinical study titled "Heart Failure and a Preserved Ejection Fraction". This will be a cross sectional study comparing patients with HFpEF and age-matched, non-HF controls recruited from the community. This design will allow for determination of biologically relevant differences in baseline ventricular and vascular function, and importantly, differences in the ability t...
What is the current status of trial NCT00586833?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2007-04. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00586833?
The interventions under investigation include: O2 consumption max bike test (PROCEDURE).
Who is sponsoring clinical trial NCT00586833?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.